The coexistence of acute aortic dissection with autosomal dominant polycystic kidney disease - Description of two hypertensive patients

Blood Pressure

Volumn 13, Issue 5, 2004, Pages 283-286

  Peczkowska, Mariola ^a   Januszewicz, Andrzej ^a   Grzeszczak, Władysław ^b   Moczulski, Dariusz ^b   Janaszek Sitkowska, Hanna ^a   Kabat, Marek ^a   Biederman, Andrzej ^a   Hendzel, Piotr ^a   Prejbisz, Aleksander ^a   Cendrowska Demkow, Iwona ^a   Zieliński, Tomasz ^a   Januszewicz, Magdalena ^c  

^a INSTITUTE OF CARDIOLOGY   (Poland)

^b MEDICAL UNIVERSITY OF SILESIA   (Poland)

^c MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

Acute aortic dissection; Autosomal dominant polycystic kidney disease

Indexed keywords

AMLODIPINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLONIDINE; ENALAPRIL; FUROSEMIDE; GLYCERYL TRINITRATE; METOPROLOL;

ADULT; AORTA DISSECTION; ARTERY WALL; ARTICLE; AUTOSOMAL DOMINANT DISORDER; CASE REPORT; COLLAPSE; COMORBIDITY; DISEASE SEVERITY; FEMALE; GENE MUTATION; GENETIC DISORDER; HUMAN; HYPERTENSION; KIDNEY FAILURE; KIDNEY POLYCYSTIC DISEASE; LETHALITY; MORTALITY; PRIORITY JOURNAL; SURVIVAL; THORACIC AORTA; THORAX PAIN; VASCULAR DISEASE;

ANEURYSM, DISSECTING; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; POLYCYSTIC KIDNEY, AUTOSOMAL DOMINANT;

EID: 9244240256     PISSN: 08037051     EISSN: None     Source Type: Journal    
DOI: 10.1080/08037050410016492     Document Type: Article

References (14)

1. Isselbacher EM. Diseases of aorta. In: Braunwald E, Zipes DP, Libby P, editors, 6th edition. Philadelphia: WB Saunders Company, 2001: 1422-56.
2. Gabow PA. Autosomal dominant polycystic kidney disease. N Engl J Med 1993; 329: 332-42.
3. Parfrey PS, Barrett BJ. Hypertension in autosomal dominant polycystic kidney disease. Curr Opin Nephrol Hypertens 1995; 4: 460-4.
4. Grunfeld JP, Bennett WM. Clinical aspects of autosomal dominant polycystic kidney disease. Curr Opin Nephrol Hypertens 1995; 4: 114-20.
5. Torra R, Nicolau C, Badenas C et al. Abdominal aortic aneurysms and autosomal dominant polycyctic kidney disease. J Am Soc Nephrol 1996; 7: 2483-6.
6. Grantham JJ. Polycystic kidney disease: from the bedside to the gene and back. Curr Opin Nephrol Hypertens 2001; 10: 533-42.
7. Osawa Y, Omori S, Nagai M, Obayashi H, Maruyama H, Gejyo F. Thoracic aortic dissection in a patient with autosomal dominant polycystic kidney disease treated with maintenance hemodialysis. J Nephrol 2000; 13: 193-5.
8. Adeola T, Adeleye O, Potts JL, Faulkner M, Oso A. Thoracic aortic dissection in a patient with autosomal dominant polycystic kidney disease. J Nat Med Assoc 2001; 93: 282-7.
9. Paynter HE, Parnham A, Feest TG, Dudley CR. Thoracic aortic dissection complicating autosomal dominant polycystic kidney disease. Nephrol Dial Transplantol 1997; 12: 1711-13.
10. Biagini A, Maffei S, Baroni M et al. Familiar clustering of aortic dissection in polycystic kidney disease. Am J Cardiol 1993; 72: 741-2.
11. Kim K, Drummond I, Ibraghimov-Beskrovnaya O, Klinger K, Arnaout MA. Polycystin 1 is required for the structural integrity of blood vessels. Proc Natl Acad Sci USA 2000; 97: 1731-6.
12. Torres VE, Cai Y, Chen X et al. Vascular expression of polycystin-2. J Am Soc Nephrol 2001; 12: 1-9.
13. Boulter C, Mulroy S, Webb S, Fleming S, Brindle K, Sanford R. Cardiovascular, skeletal and renal defects in mice with targeted disruption of Pkd1 gene. Proc Natl Acad Sci USA 2001; 98: 12174-9.
14. Wilson PD. Polycystic kidney disease. N Engl J Med 2004; 350: 151-64.